Evidence map›Paper›PMID 38252330›Full record

ArticleMaternal and child health journal2024

Short term Outcomes of COVID-19 Vaccines Among Lactating Mother and Child Dyads in Bangladesh: A Multi-centre, Cross-sectional Study.

Jia Ming Low, Sharmin Afroze, Mohammod Abdullah Al Mamun, Sadia Afroze, Sabrina Tisha, Md Arif Hossain, Md Abdul Mannan, Sanjoy Kumer Dey, Zubair Amin, Mohammod Shahidullah

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Maternal and child health journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jia Ming Low *Department of Neonatology, Khoo Teck Puat-National University Children's Medical Institute, National University Hospital, Singapore, Singapore.
Sharmin Afroze *Department of Neonatology, Dr. M R Khan Shishu Hospital and Institute of Child Health, Mirpur, Dhaka, Bangladesh.
Mohammod Abdullah Al MamunDepartment of Paediatric Cardiology, Bangladesh Shishu (Children) Hospital and Institute, Sher- E-Bangla Nagar, Dhaka, Bangladesh.
Sadia AfrozeThe Second Urban Primary Health Care Project (UPHCSDP-II), DSCC, PA-2, BAPSA, Dhaka, Bangladesh.
Sabrina TishaProjahnmo Research Foundation, Dhaka, Bangladesh.
Md Arif HossainDepartment of Neonatology, Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka, Bangladesh.
Md Abdul MannanDepartment of Neonatology, Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka, Bangladesh.
Sanjoy Kumer DeyDepartment of Neonatology, Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka, Bangladesh.
Zubair AminDepartment of Neonatology, Khoo Teck Puat-National University Children's Medical Institute, National University Hospital, Singapore, Singapore. paeza@nus.edu.sg.ORCID http://orcid.org/0000-0002-4430-5012
Mohammod ShahidullahDepartment of Neonatology, Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka, Bangladesh.

Funding

National University Hospital NCSP2.0/2023/PVO/LJM
6 · The paper itself

Abstract

introductionThe aims of the study are to: (1) determine the short-term reactogenicity of WHO-approved COVID-19 vaccines (i.e., Pfizer-BioNTech, Moderna, Sinovac, Oxford-AstraZeneca, Johnson and Johnson, Covaxin) amongst lactating women and their children, and 2) evaluate lactation-related outcomes following the same vaccines in Bangladesh.

methodsThis was a multi-centre, self-reported, cross-sectional study of lactating woman-child dyads in Bangladesh. Demographics, past medical history, breastfeeding history and clinical outcomes of lactating woman-child dyads at least 7 days after the last dose of vaccine were determined through a structured questionnaire.

resultsThere were 750 participants from four centres. The mean age of lactating women and children surveyed were 27.6 (SD ± 4.6) years and 10.3 (SD ± 6.7) months, respectively. Majority (81.2%; 608 of 750) received 2 doses of COVID-19 vaccinations while lactating. Almost all (99.9%; 749 of 750) vaccinated lactating women surveyed reported no change in human milk supply. More than half of the participants (56.9%; 373 of 656) reported no symptoms after both doses of COVID-19 vaccines. There were no serious adverse events such as anaphylaxis or hospital admission. Majority of the lactating women (98.9%; 742 of 750) reported that the children whom they breastfed had no symptoms such as fever or cough. DISCUSSION: This large study of lactating woman-child dyads in Bangladesh, who received a diverse range of WHO-approved COVID-19 vaccines, showed no serious short-term adverse effects.

Indexed as

Breast FeedingCOVID-19COVID-19 VaccinesLactationSARS-CoV-2AdultBangladeshCross-Sectional StudiesFemaleHumansInfantMaleMilk, HumanMothersSurveys and QuestionnairesYoung AdultCOVID-19 VaccinesBreastfeedingCOVID-19InfantLactationVaccines

Identifiers

PMID38252330

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.